Back to today’s briefing

Story perspectives

Revolutionary Trials Aim to Protect Cancer Patients from Infections

5/23/2025

33 3

Summary

Story summary

At Memorial Sloan Kettering, the Infectious Diseases and Allergy Service, under Tobias Hohl's leadership, is on a mission to shield cancer patients from infections. Their groundbreaking research delves into antimicrobial agents and the microbiome's power against antibiotic resistance. Exciting clinical trials are exploring microbiome transplants to enhance treatment success and minimize complications for vulnerable patients.

1 of 1

Story summary

At Memorial Sloan Kettering, the Infectious Diseases and Allergy Service, under Tobias Hohl's leadership, is on a mission to shield cancer patients from infections. Their groundbreaking research delves into antimicrobial agents and the microbiome's power against antibiotic resistance. Exciting clinical trials are exploring microbiome transplants to enhance treatment success and minimize complications for vulnerable patients.